• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Diabetes mellitus as a risk factor for SARS-CoV-2 test positivity in Mexico: A propensity score matched study.糖尿病作为墨西哥人 SARS-CoV-2 检测阳性的一个风险因素:一项倾向评分匹配研究。
Diabetes Res Clin Pract. 2021 Aug;178:108953. doi: 10.1016/j.diabres.2021.108953. Epub 2021 Jul 21.
2
Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx).感染新型冠状病毒2(SARS-CoV-2)的孕妇死亡和患肺炎风险更高:一项全国性前瞻性队列(COV19Mx)的倾向评分匹配分析
Ultrasound Obstet Gynecol. 2021 Feb;57(2):224-231. doi: 10.1002/uog.23575.
3
Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.组胺 2 受体拮抗剂和质子泵抑制剂与 SARS-CoV-2 感染风险降低相关,无论是否存在糖尿病、高血压和血脂异常等合并症:一项倾向评分匹配的全国队列研究。
J Korean Med Sci. 2023 Apr 3;38(13):e99. doi: 10.3346/jkms.2023.38.e99.
4
Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study.过敏疾病与 COVID-19 的易感性和严重程度:一项全国性队列研究。
J Allergy Clin Immunol. 2020 Oct;146(4):790-798. doi: 10.1016/j.jaci.2020.08.008. Epub 2020 Aug 15.
5
Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.2020年疫情期间一项横断面研究:SARS-CoV-2逆转录实时聚合酶链反应(rtRT-PCR)检测呈阳性的墨西哥儿童和成人中哮喘的低患病率
Allergol Immunopathol (Madr). 2021 May 1;49(3):1-7. doi: 10.15586/aei.v49i3.7. eCollection 2021.
6
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.在 COVID 症状研究应用程序的英国用户中,疫苗接种后 SARS-CoV-2 感染的风险因素和疾病特征:一项前瞻性、基于社区的、嵌套的病例对照研究。
Lancet Infect Dis. 2022 Jan;22(1):43-55. doi: 10.1016/S1473-3099(21)00460-6. Epub 2021 Sep 1.
7
Association between new-onset anosmia and positive SARS-CoV-2 tests among people accessing outpatient testing in Toronto, Ontario: a retrospective cross-sectional study.安大略省多伦多市接受门诊检测人群中新发嗅觉丧失与 SARS-CoV-2 检测阳性之间的关联:一项回顾性横断面研究。
CMAJ Open. 2021 Dec 7;9(4):E1134-E1140. doi: 10.9778/cmajo.20210085. Print 2021 Oct-Dec.
8
COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.检测时的 COVID-19 症状与 SARS-CoV-2 检测门诊患者的阳性率之间的关系。
PLoS One. 2021 Dec 10;16(12):e0260879. doi: 10.1371/journal.pone.0260879. eCollection 2021.
9
Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.墨西哥门诊和住院患者严重急性呼吸综合征冠状病毒 2 感染后生存的决定因素。
Public Health. 2020 Dec;189:66-72. doi: 10.1016/j.puhe.2020.09.014. Epub 2020 Sep 30.
10
Association of COVID-19 Infection With Incident Diabetes.COVID-19 感染与新发糖尿病的关联。
JAMA Netw Open. 2023 Apr 3;6(4):e238866. doi: 10.1001/jamanetworkopen.2023.8866.

引用本文的文献

1
Avocado Oil: Recent Advances in Its Anti-diabetic Potential.鳄梨油:其抗糖尿病潜力的最新进展
Curr Med Sci. 2025 Feb;45(1):11-24. doi: 10.1007/s11596-025-00010-w. Epub 2025 Feb 25.

本文引用的文献

1
Diagnostic performance and clinical implications of rapid SARS-CoV-2 antigen testing in Mexico using real-world nationwide COVID-19 registry data.利用真实世界的全国 COVID-19 注册数据评估墨西哥快速 SARS-CoV-2 抗原检测的诊断性能和临床意义。
PLoS One. 2021 Aug 31;16(8):e0256447. doi: 10.1371/journal.pone.0256447. eCollection 2021.
2
Telemedicine to deliver diabetes care in low- and middle-income countries: a systematic review and meta-analysis.远程医疗在中低收入国家提供糖尿病护理:系统评价和荟萃分析。
Bull World Health Organ. 2021 Mar 1;99(3):209-219B. doi: 10.2471/BLT.19.250068. Epub 2020 Nov 29.
3
Covid-19: Many poor countries will see almost no vaccine next year, aid groups warn.新冠疫情:援助组织警告称,许多贫困国家明年几乎不会有疫苗可用。
BMJ. 2020 Dec 11;371:m4809. doi: 10.1136/bmj.m4809.
4
COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes.COVID-19 在糖尿病患者群体中的严重程度增加了两倍:对 1 型和 2 型糖尿病患者中疫情影响的前瞻性分析。
Diabetes Care. 2021 Feb;44(2):526-532. doi: 10.2337/dc20-2260. Epub 2020 Dec 2.
5
Incremental Risk of Developing Severe COVID-19 Among Mexican Patients With Diabetes Attributed to Social and Health Care Access Disadvantages.墨西哥糖尿病患者因社会和医疗保健机会劣势而发展为重症 COVID-19 的增量风险。
Diabetes Care. 2021 Feb;44(2):373-380. doi: 10.2337/dc20-2192. Epub 2020 Nov 18.
6
Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19.糖尿病作为新冠病毒病住院患者早期预后不良的一个风险因素
Diabetes Care. 2020 Dec;43(12):2938-2944. doi: 10.2337/dc20-1506. Epub 2020 Aug 26.
7
Prevalence of Chronic Disease in Laboratory-Confirmed COVID-19 Cases and U.S. Adults (2017-2018).实验室确诊的新冠肺炎病例和美国成年人(2017 - 2018年)中的慢性病患病率。
Diabetes Care. 2020 Oct;43(10):e127-e128. doi: 10.2337/dc20-1640. Epub 2020 Aug 12.
8
A model of disparities: risk factors associated with COVID-19 infection.一种差异模型:与 COVID-19 感染相关的风险因素。
Int J Equity Health. 2020 Jul 29;19(1):126. doi: 10.1186/s12939-020-01242-z.
9
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.预测因 SARS-CoV-2 导致的死亡率:一个将肥胖和糖尿病与墨西哥 COVID-19 结局相关联的机制评分。
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa346.
10
Prevalence of previously diagnosed diabetes and glycemic control strategies in Mexican adults: ENSANUT-2016.墨西哥成年人中既往诊断糖尿病的患病率和血糖控制策略:ENSANUT-2016。
PLoS One. 2020 Apr 16;15(4):e0230752. doi: 10.1371/journal.pone.0230752. eCollection 2020.

糖尿病作为墨西哥人 SARS-CoV-2 检测阳性的一个风险因素:一项倾向评分匹配研究。

Diabetes mellitus as a risk factor for SARS-CoV-2 test positivity in Mexico: A propensity score matched study.

机构信息

Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA.

Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico.

出版信息

Diabetes Res Clin Pract. 2021 Aug;178:108953. doi: 10.1016/j.diabres.2021.108953. Epub 2021 Jul 21.

DOI:10.1016/j.diabres.2021.108953
PMID:34298043
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8331361/
Abstract

AIMS

We sought to investigate whether individuals with diabetes have a higher likelihood of testing positive for SARS-CoV-2, as a proxy for infection risk, than individuals without diabetes.

METHODS

We conducted a cross-sectional study of publicly available data among a Mexican population, totaling 2,314,022 adults ≥ 18 years who underwent SARS-CoV-2 testing between March 1 and December 20, 2020. We used 1:1 nearest neighborhood propensity score matching by diabetes status to account for confounding among those with and without diabetes.

RESULTS

In the overall study population, 1,057,779 (45.7%) individuals tested positive for SARS-CoV-2 and 270,486 (11.7%) self-reported diabetes. After propensity score matching, patient characteristics were well-balanced, with 150,487 patients in the diabetes group (mean [SD] age 55.9 [12.7] years; 51.3% women) and 150,487 patients in the no diabetes group (55.5 [13.3] years; 50.3% women). The strictest matching algorithm (1:1 nearest neighbor) showed that compared to individuals without diabetes, having diabetes was associated with 9.0% higher odds of having a positive SARS-CoV-2 test (OR 1.09 [95% CI: 1.08-1.10]).

CONCLUSIONS

Presence of diabetes was associated with higher odds of testing positive for SARS-CoV-2, which could have important implications for risk mitigation efforts for people with diabetes at risk of SARS-CoV-2 infection.

摘要

目的

我们旨在研究糖尿病患者与非糖尿病患者相比,其 SARS-CoV-2 检测呈阳性的可能性是否更高,以作为感染风险的替代指标。

方法

我们对墨西哥人群中公开可用的数据进行了横断面研究,共纳入 2314022 名年龄≥18 岁的成年人,他们在 2020 年 3 月 1 日至 12 月 20 日期间接受了 SARS-CoV-2 检测。我们使用按糖尿病状态进行的 1:1 最近邻居倾向评分匹配来控制糖尿病患者和非糖尿病患者之间的混杂因素。

结果

在整个研究人群中,有 1057779 名(45.7%)个体 SARS-CoV-2 检测呈阳性,270486 名(11.7%)自我报告患有糖尿病。在倾向评分匹配后,患者特征得到了很好的平衡,糖尿病组有 150487 名患者(平均[标准差]年龄 55.9[12.7]岁;51.3%为女性),无糖尿病组有 150487 名患者(55.5[13.3]岁;50.3%为女性)。最严格的匹配算法(1:1 最近邻居)显示,与无糖尿病患者相比,患有糖尿病与 SARS-CoV-2 检测呈阳性的几率增加 9.0%相关(比值比 1.09[95%置信区间:1.08-1.10])。

结论

糖尿病的存在与 SARS-CoV-2 检测呈阳性的几率增加相关,这对于有感染 SARS-CoV-2 风险的糖尿病患者的风险缓解努力可能具有重要意义。